BPA Call 36E79718A0010-36C24719K0046
- This federal contract award was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The $639,352.61 Blanket Purchase Agreement (BPA) call contract is for the delivery of medication, specifically pharmaceuticals and drugs, under the General Services Administration (GSA) Pharmaceuticals and Drugs Schedule. The contract does...
- This is a federal contract award to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals, to provide the pharmaceutical product Prolastin to the Department of Veterans Affairs (VA). The contract was issued as a Blanket Purchase Agreement (BPA) call under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule contract vehicle. The fixed-price contract has a ceiling value of $86,315.28 and a period of performance ending on...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call order awarded by the U.S. Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit pharmaceutical manufacturer and supplier. The order is for the VA's Pharmacy Ordering Officer to purchase pharmaceuticals for the 2nd and 3rd quarters of fiscal year 2017. The award has a ceiling value of $93,893.76 and does not utilize any small business set-asides. Grifols has provided various pharmaceutical products such as...
- This is a Firm Fixed Price call order under a Blanket Purchase Agreement (BPA) between the Department of Veterans Affairs (VA) and Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract, valued at $84,785.28, is for the VA to order Prolastin-C, a plasma-derived alpha1-proteinase inhibitor, for Fiscal Year 2018. The contract does not have a small business set-aside. Grifols is the prime contractor and has provided similar...
- This is a $93,183.36 firm fixed price Blanket Purchase Agreement (BPA) call contract awarded by the U.S. Department of Veterans Affairs to Grifols Therapeutics LLC, a manufacturer of pharmaceuticals and biopharmaceuticals. The contract is for the provision of the pharmaceutical product Prolastin to the Veterans Integrated Service Network 7 for the 2018 fiscal year. The contract was awarded on March 29, 2018 and has an ultimate completion date of September 30, 2018. This contract was not set...
- This federal contract award is a delivery order issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The order is for various pharmacy supplies and pharmaceuticals, including Prolastin, Prolastin-C, and immune globulin, under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule contract. The total...
- This contract award is for the pharmaceutical product PROLASTIN, provided by Grifols Therapeutics LLC, a for-profit manufacturer of pharmaceuticals and biopharmaceuticals. The contract, which does not utilize any set-asides, was awarded on October 19, 2018 by the Department of Veterans Affairs Veterans Health Administration for a total potential value of $100,131.84. The contract is a Blanket Purchase Agreement (BPA) call, with a firm-fixed price, and is associated with the Pharmaceuticals and...
- This is a federal contract award made by the Veterans Integrated Service Network 2 (VISN 2) of the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is for the product PROLASTIN, a pharmaceutical, and is a Blanket Purchase Agreement (BPA) call order under the VA's Pharmaceuticals and Drugs GSA Schedule. The contract has a ceiling value of $161,722.32 and a period of performance ending on...
- This contract was awarded by the Department of Veterans Affairs Veterans Health Administration to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price, for the delivery of the pharmaceutical product PROLASTIN. The contract has a potential value of $203,986.73 and a completion date of February 6, 2021. The contract was awarded on February 7, 2020 and does not...
- This is a Firm Fixed Price Blanket Purchase Agreement (BPA) call order awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is for the delivery of PROLASTIN-C, a pharmaceutical product, with a ceiling value of $214,014.72 and a period of performance through September 30, 2016. The contract is issued under the Pharmaceuticals and Drugs GSA Schedule vehicle and does not utilize...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- V797D30042-36E79718A0010Blanket Purchase Agreement
- 36E79718A0010-36C24719K0046BPA Call
This federal contract award is for a Blanket Purchase Agreement (BPA) call from the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 7 to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is for the delivery of Prolastin, a pharmaceutical product, with a potential value of $125,209.92. The contract does not utilize any small business set-asides and is a Firm Fixed Price contract under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule. Grifols Therapeutics LLC has provided similar pharmaceutical products such as Prolastin-C and immune globulin to the VA and Defense Logistics Agency through prior federal contract awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $125.2k | 10/26/18 |